These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19941407)

  • 1. Accelerated degradation of ibuprofen in tablets.
    Cory WC; Harris C; Martinez S
    Pharm Dev Technol; 2010 Dec; 15(6):636-43. PubMed ID: 19941407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory and pharmacokinetics evaluation of PEGylated ibuprofen tablet formulation.
    Mumuni M; Kenechukwu FC; Chime SA; Ogbonna JD; Mora AT
    Drug Deliv; 2014 Jun; 21(4):315-9. PubMed ID: 24191762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and in-vitro evaluation of dextrin matrix tablet of Ibuprofen for colon specific drug delivery.
    Salunkhe KS; Kulkarni MV
    Pak J Pharm Sci; 2008 Jan; 21(1):17-20. PubMed ID: 18166513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of surfactant/cosurfactant synergism impact on ibuprofen solubilization capacity and drug release characteristics of nonionic microemulsions.
    Djekic L; Primorac M; Filipic S; Agbaba D
    Int J Pharm; 2012 Aug; 433(1-2):25-33. PubMed ID: 22579578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of Block Copolymer Costabilized Nonionic Microemulsions and Their In Vitro and In Vivo Assessment as Carriers for Sustained Regional Delivery of Ibuprofen via Topical Administration.
    Djekic L; Martinovic M; Stepanović-Petrović R; Tomić M; Micov A; Primorac M
    J Pharm Sci; 2015 Aug; 104(8):2501-12. PubMed ID: 26045240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated stability of Ibuprofen-Eudragit RSPM sustained release tablets, IR and DSC solid stability testing.
    Abdel Rahman AA; Aboutaleb AE; Stamm A; Samy EM; Abdel-Rahman SI
    J Pharm Belg; 1993; 48(6):463-70. PubMed ID: 8133428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and hydrolytic behaviour of 2-mercaptoethyl ibuprofenate-polyethylene glycol conjugate as a novel transdermal prodrug.
    Davaran S; Rashidi MR; Hashemi M
    J Pharm Pharmacol; 2003 Apr; 55(4):513-7. PubMed ID: 12803773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of controlled release ibuprofen matrix tablets by direct compression technique.
    Patel N; Madan P; Lin S
    Pharm Dev Technol; 2011 Feb; 16(1):1-11. PubMed ID: 20491616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Miniaturized approach for excipient selection during the development of oral solid dosage form.
    Raijada D; Müllertz A; Cornett C; Munk T; Sonnergaard J; Rantanen J
    J Pharm Sci; 2014 Mar; 103(3):900-8. PubMed ID: 24436033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation development and investigation of ibuprofen controlled release tablets with hydrophilic polymers and the effect of co-excipients on drug release patterns.
    Jan SU; Khan GM; Hussain I
    Pak J Pharm Sci; 2012 Oct; 25(4):751-6. PubMed ID: 23009990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of storage on in-vitro release of ibuprofen from sugar coated tablets.
    Saville DJ
    Int J Pharm; 2001 Aug; 224(1-2):39-49. PubMed ID: 11472813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of cryoprotectants on the freeze-drying of ibuprofen-loaded solid lipid microparticles (SLM).
    Zhang L; Liu L; Qian Y; Chen Y
    Eur J Pharm Biopharm; 2008 Jun; 69(2):750-9. PubMed ID: 18280121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets.
    Pabari RM; Ramtoola Z
    Int J Pharm; 2012 Jul; 430(1-2):18-25. PubMed ID: 22465631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of formulation excipients on the penetration and lateral diffusion of ibuprofen on and within the stratum corneum following topical application to humans.
    Gee CM; Watkinson AC; Nicolazzo JA; Finnin BC
    J Pharm Sci; 2014 Mar; 103(3):909-19. PubMed ID: 24421242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of physicochemical factors affecting the stability of a pH-modulated solid dispersion and a tablet during storage.
    Tran PH; Tran TT; Park JB; Min DH; Choi HG; Han HK; Rhee YS; Lee BJ
    Int J Pharm; 2011 Jul; 414(1-2):48-55. PubMed ID: 21565260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two release rates from monolithic carboxymethyl starch tablets: formulation, characterization, and in vitro/in vivo evaluation.
    Le TC; Mateescu MA
    Drug Deliv Transl Res; 2017 Aug; 7(4):516-528. PubMed ID: 28386870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibuprofen release kinetics from controlled-release tablets granulated with aqueous polymeric dispersion of ethylcellulose II: influence of several parameters and coexcipients.
    Majid Khan G; Zhu JB
    J Control Release; 1998 Dec; 56(1-3):127-34. PubMed ID: 9801436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the potential for direct compaction of a fine ibuprofen powder dry-coated with magnesium stearate.
    Qu L; Zhou QT; Gengenbach T; Denman JA; Stewart PJ; Hapgood KP; Gamlen M; Morton DA
    Drug Dev Ind Pharm; 2015 May; 41(5):825-37. PubMed ID: 24738790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of ibuprofen microparticle and improvement of the dissolution.
    Ren F; Su J; Xiong H; Tian Y; Ren G; Jing Q
    Pharm Dev Technol; 2017 Feb; 22(1):63-68. PubMed ID: 27055726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of Small Amounts of Glidant Capable of Improving the Tensile Strength of Ibuprofen Tablets.
    Ono T; Ishikawa A; Yonemochi E
    Chem Pharm Bull (Tokyo); 2021; 69(4):374-382. PubMed ID: 33790082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.